Scientific advisory for biotechnology & digital health innovation
Turning scientific complexity into informed decisions.
Eloria Health Inc. provides independent scientific advisory to biotechnology companies and digital health innovators, offering expert evaluation of complex scientific evidence to support research strategy and product development.

About
About Our Founder & CEO

Dr. Mitra Shokrollahi, PhD
Founder & Chief Executive Officer
Dr. Mitra Shokrollahi is a PhD-trained scientist with a distinguished multidisciplinary background spanning molecular genetics, DNA repair, cancer biology, translational pharmacology, and gastrointestinal physiology. Her work focuses on how complex biological systems interact across genetics, immunity, hormones, metabolism and the gut microbiome to influence disease development, treatment response, and long-term health.
Her scientific approach is rooted in systems thinking, precision medicine, and interdisciplinary biology, integrating knowledge across fields to uncover biological relationships that may not be apparent through conventional product development or investment due diligence. This perspective enables her to translate complex biomedical science into meaningful strategic insights that support research, biotechnology, and digital health innovation.
Built on Scientific Foundations
Dr. Shokrollahi’s career has been driven by a longstanding commitment to decoding the biological mechanisms underlying human disease. Her doctoral studies in Laboratory Medicine and Pathobiology at the University of Toronto led to the discovery of a previously unrecognized DNA repair mechanism, advancing the understanding of genome stability with important implications for cancer biology and aging. This pioneering research was published in the high-impact journal Nature Structural & Molecular Biology, recognized with multiple awards, resulted in an international patent application, and was featured on major scientific news platforms, including ScienceDaily and EurekAlert! (AAAS).
Her earlier graduate research explored receptor-mediated signalling pathways in the gastrointestinal tract, contributing key insights toward the development of safer, targeted therapeutics. This profound breadth of expertise enables her to connect ideas across traditionally separate fields, recognize emerging clinical opportunities, evaluate biomedical assets with scientific rigor, and approach complex scientific questions from a broader biological perspective.
Inspired by Experience
Dr. Shokrollahi’s perspective is uniquely shaped not only by multidisciplinary scientific training but also by firsthand experience navigating the uncertainty, complexity, and often fragmented nature of modern healthcare as a patient. This combination of scientific expertise and patient perspective has given her a deeper understanding of the gap between rapidly evolving biomedical breakthroughs and their practical application. Alongside her research career, this experience has provided her with valuable insights into the real-world challenges that healthcare innovators must address. This dual perspective forms the foundation of Eloria Health’s approach to scientific advisory.
Today, Eloria Health Inc. provides scientific advisory services to health technology innovators, biotechnology ventures, and investors. Our mission is to bridge the gap between biological science, technology, and real-world healthcare by helping organizations evaluate scientific opportunities, assess innovation potential, make informed strategic decisions, and translate complex biomedical knowledge into clinically meaningful health solutions.
How we can help
Our Areas of Focus
Bridging scientific complexity and strategic decision-making.

Scientific Advisory for Biotechnology Ventures
Eloria Health Inc. provides scientific advisory services to early-stage biotechnology ventures, investors, and research teams. We evaluate complex scientific evidence to help organizations and investors assess therapeutic opportunities, validate target rationale, identify conceptual blind spots, and make informed strategic decisions.
Areas of Support
- Scientific & Asset Due Diligence: Independent evaluation of biological rationale, mechanistic plausibility, and published preclinical evidence to support asset acquisition, licensing, funding proposals, or partnership decisions.
- Mechanistic Pathway Evaluation: In-depth analysis of biological pathways, disease mechanisms, and proposed modes of action (MoA) to identify conceptual limitations, underlying assumptions, and evidence gaps.
- Scientific Evidence Review & Literature Analysis: Critical appraisal of complex biomedical literature to map scientific knowledge gaps, evaluate competing therapeutic approaches, and strengthen R&D strategy.

Scientific Advisory for Digital Health Innovation
Eloria Health Inc. partners with technical teams, product managers, and health technology founders to translate complex medical and biological concepts into structured scientific and clinical frameworks. We provide the domain expertise to help ensure digital products are biologically accurate, clinically relevant, and aligned with current biomedical knowledge.
Areas of Support
- Clinical & Biological Logic Mapping: Translating complex physiological mechanisms, disease features, biomedical evidence, and clinical guidelines into structured frameworks that technical teams can incorporate into digital health products.
- Product Concept & Feature Strategy: Evaluating digital health concepts, tracking modules, and user flows to ensure product features are scientifically meaningful, clinically relevant, and aligned with intended outcomes.
- Domain Translation for Tech Teams: Bridging the gap between technology development and biomedical science by helping technical teams incorporate scientifically accurate health concepts into digital product design.
Our approach
Integrating Biology Across Disciplines
Complex health challenges rarely exist within a single biological pathway. We integrate knowledge across molecular biology, disease mechanisms, physiology, and emerging biomedical research to build a broader understanding of biological systems and support strategic decisions in biotechnology and digital health innovation.
Molecular & Cell Biology
Analyzing disease mechanisms, biological pathways, and molecular drivers of disease to evaluate scientific rationale and identify meaningful biological insights.
Systems Biology & Physiology
Evaluating how biological processes interact across tissues, organs, immune pathways, and regulatory networks to uncover broader biological relationships and potential limitations.
Translational Science
Connecting mechanistic discoveries with therapeutic concepts, biomarkers, and digital health frameworks to help bridge the gap between laboratory research and real-world health applications.
Start a conversation
Translate scientific complexity into informed decisions
Whether you are developing a therapeutic concept, evaluating emerging research, or building a digital health product, Eloria Health Inc. provides scientific guidance to help navigate complex biological questions.
